MedPath

Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial

Not Applicable
Completed
Conditions
Cocaine-related Disorders
Interventions
Behavioral: Cognitive behavioral therapy (CBT)
Registration Number
NCT00877435
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

The purpose of this study is to determine whether prize-based contingency management (prizeCM) combined with cognitive behavioral therapy (CBT) is more effective in the treatment of of cocaine-dependent patients compared to CBT only. Patients were randomized to prizeCM + CBT (experimental group) or to CBT (control group) an treated over 24 weeks. It is the first trial of this type in Europe.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • cocaine dependence, aged 18 or older, other dependences
Exclusion Criteria
  • severe somatic, brain, or psychiatric disease, attention deficit disorders with medication methylphenidate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Cognitive behavioral therapy (CBT)Cognitive behavioral therapy (CBT)
1Cognitive behavioral therapy (CBT)Cognitive behavioral therapy (CBT) + prize-based contingency management (prizeCM)
Primary Outcome Measures
NameTimeMethod
retention in treatment, cocaine abstinence24 weeks

cocaine abstinence: at least 3 consecutive weeks of cocaine abstinence, the maximum number of weeks of continous abstinence and proportions of cocaine-free urine samples during the entire 24-week and at 6-month follow-up.

Secondary Outcome Measures
NameTimeMethod
patients' satisfaction with the therapy, clinical measures24 weeks

patients' satisfaction with prize-based contingency management and with CBT

Trial Locations

Locations (2)

Fondation Phenix

🇨🇭

Geneva, Switzerland

Universitäre Psychiatrischen Kliniken

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath